Heart Rate in Patients with SARS-CoV-2 Infection: Prevalence of High Values at Discharge and Relationship with Disease Severity
Authors:
- Alessandro MalobertiAMAlessandro Maloberti
- Nicola UghiNUNicola Ughi
- Davide Paolo BernasconiDBDavide Paolo Bernasconi
- Paola ReboraPRPaola Rebora
- Iside CartellaICIside Cartella
- Enzo GrassoEGEnzo Grasso
- Deborah LenociDLDeborah Lenoci
- Francesca Del GaudioFGFrancesca Del Gaudio
- Michela AlgeriMAMichela Algeri
- Sara ScarpelliniSSSara Scarpellini
- Enrico PernaEPEnrico Perna
- Alessandro VerdeAVAlessandro Verde
Open Access
- 28 November 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5590
Abstract
The most common arrhythmia associated with COronaVIrus-related Disease (COVID) infection is sinus tachycardia. It is not known if high Heart Rate (HR) in COVID is simply a marker of higher systemic response to sepsis or if its persistence could be related to a long-term autonomic dysfunction. The aim of our work is to assess the prevalence of elevated HR at discharge in patients hospitalized for COVID-19 and to evaluate the variables associated with it. We enrolled 697 cases of SARS-CoV2 infection admitted in our hospital after February 21 and discharged within 23 July 2020. We collected data on clinical history, vital signs, laboratory tests and pharmacological treatment. Severe disease was defined as the need for Intensive Care Unit (ICU) admission and/or mechanical ventilation. Median age was 59 years (first-third quartile 49, 74), and male was the prevalent gender (60.1%). 84.6% of the subjects showed a SARS-CoV-2 related pneumonia, and 13.2% resulted in a severe disease. Mean HR at admission was 90 ± 18 bpm with a mean decrease of 10 bpm to discharge. Only 5.5% of subjects presented HR > 100 bpm at discharge. Significant predictors of discharge HR at multiple linear model were admission HR (mean increase = β = 0.17 per bpm, 95% CI 0.11; 0.22, p < 0.001), haemoglobin (β = −0.64 per g/dL, 95% CI −1.19; −0.09, p = 0.023) and severe disease (β = 8.42, 95% CI 5.39; 11.45, p < 0.001). High HR at discharge in COVID-19 patients is not such a frequent consequence, but when it occurs it seems strongly related to a severe course of the disease.Keywords
Funding Information
- Italian Ministry of University and Research (MiUR) (Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to clinic))
- A. De Gasperis Cardiology and Cardiac Surgery Foundation (N/A)
This publication has 35 references indexed in Scilit:
- Identifying Patients With Sepsis on the Hospital WardsChest, 2017
- I f Channel Inhibition With Ivabradine Does Not Improve Cardiac and Vascular Function in Experimental Septic ShockShock, 2016
- Evidence for a critical role of the sympathetic nervous system in hypertensionJournal of the American Society of Hypertension, 2016
- Effects of chronic carotid baroreceptor activation on arterial stiffness in severe heart failureClinical Research in Cardiology, 2016
- Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trialIntensive Care Medicine, 2015
- 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal SyncopeHeart Rhythm, 2015
- Autonomic Symptoms at Baseline and Following Infectious Mononucleosis in a Prospective Cohort of AdolescentsArchives of Pediatrics & Adolescent Medicine, 2011
- Cardiovascular complications of severe acute respiratory syndromePostgraduate Medical Journal, 2006
- Tachycardia amongst subjects recovering from severe acute respiratory syndrome (SARS)International Journal of Cardiology, 2005
- Heart rate variability and cardiovascular mortalityCurrent Atherosclerosis Reports, 2002